More than one billion doses of COVID-19 vaccines have been delivered through COVAX, the vaccine pillar of the Access to COVID-19 Tools Accelerator (ACT-A), marking a significant milestone. The 1 billion vaccine doses were delivered to 144 countries in less than one year.
Gavi, the Vaccine Alliance is spearheading 'Break COVID Now,' the Investment Opportunity for the Gavi COVAX Advance Market Commitment (Gavi COVAX AMC) which aims to raise US$5.2 billion in new funding to support new challenges and global equitable vaccine distribution.
- EU Institutions: In response to the Investment Opportunity, European Investment Bank (EIB) President Werner Hoyer announced that the EIB will make €300 million (US$339 million) in financing available to COVAX through a cost-sharing facility. The EIB’s financing will enable COVAX to quickly secure and deploy COVID-19 vaccine doses for lower- and middle-income countries, particularly targeting those on the African continent. The EIB provided €400 million (US$452 million) in loans for COVAX in December of 2020 and another €200 million (US$226 million) in November of 2021.
- Netherlands: Dutch Minister of Foreign Trade and Development Cooperation, Liesje Schreinemacher, pledged €20 million (US$23 million) for 2022 in the Investment Opportunity. This pledge brings total Dutch support up to €90 million (US$103 million) for the COVAX facility. Schreinemacher called on both public and private partners to make a financial contribution to the ACT-A and COVAX, emphasizing the shared responsibility of all nations to vaccinate the world population and reopen economies to end the pandemic.
- Canada: At the end of 2021, Canada committed to donating the equivalent of at least 200 million doses to COVAX by the end of 2022. Canada is expected to continue making substantial contributions to COVAX throughout the year.
- Norway: Norway has pledged NOK500 million (US$ million) thus far for COVAX in 2022.
- Spain: Spanish Minister of Foreign Affairs, European Union and Cooperation José Manuel Albares pledged €3.5 million (US$4 million) to COVAX at the Investment Opportunity. Spain pledged €10 million (US$11 million) to Gavi's core vaccination activities in 2022, including support for the first malaria vaccine rollout.